News | April 07, 2015

United Kingdom to Receive First Three Proton Beam Therapy Centers

First center will be operational in 2016, remaining two by 2017

UK, United Kingdom, proton beam therapy centers, Proton Partners International

April 7, 2015 — The United Kingdom is to get its first three proton beam therapy centers, marking a significant breakthrough in the provision of cancer treatment. Cardiff-based Proton Partners International Ltd is to open the treatment centers in Cardiff, London and Northumberland by 2017; the first - Cardiff - will be operational next year. The centers will be available for National Health Service (NHS) patients from England, Scotland and Wales, medically-insured private patients and self-paying patients.

Proton Partners International was formed following discussions between Prof. Sir Chris Evans, the leading life sciences entrepreneur, and leading U.K. life sciences and healthcare investors on addressing cancer treatment in the United Kingdom. Institutional and private investors have committed to almost £100m equity finance in the company.

Prof. Gordon McVie, senior consultant at the European Institute of Oncology, has been appointed chairman, and Prof. Karol Sikora has agreed to become chief medical adviser to the company, alongside a range of renowned cancer and healthcare experts.

McVie said: "This is an exciting and important development of the provision of cancer treatment in the U.K. As things stand, patients who can benefit from this treatment have to go abroad for treatment, often at great expense to the NHS. The creation of these centers will go a long way to ensuring the very best of treatment is available in the U.K."

Sikora said: "I was delighted to be approached by Sir Chris as there are only 40 proton beam therapy centers around the world and a pressing need for more. In the U.K. there are none. Given the aging population, there will be a significant rise in the number of cancer cases in the U.K., and therefore we should do what is necessary to provide the appropriate level and type of care."

Evans and his team at Arthurian Life Sciences, which manages the £100 million Wales Life Sciences Investment Fund established by the Welsh Government, are investing in the company through the fund.

In addition to state-of-the-art Proton Partners' treatment services, the Cardiff center will provide conventional radiotherapy, chemotherapy and supportive care. This could then be offered through other centers.

In the future, Proton Partners International intends to develop further proton therapy centers in Asia, the Middle East and Africa.

The government has announced that it will create two NHS proton beam therapy units, which will open in 2018.

For more information: www.nhs.uk

Related Content

IBA Releases Razor Nano Ionization Chamber
News | Proton Therapy | September 22, 2017
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest a
Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Overlay Init